NCT05605808

Brief Summary

The purpose of the study was to investigate the impact of aerobic exercise combined with diet protocol on the immune system in post-mastectomy patients receiving chemotherapy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

October 8, 2022

Completed
27 days until next milestone

First Posted

Study publicly available on registry

November 4, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 21, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2023

Completed
Last Updated

November 4, 2022

Status Verified

November 1, 2022

Enrollment Period

9 months

First QC Date

October 8, 2022

Last Update Submit

November 3, 2022

Conditions

Keywords

Aerobic exercisesDiet therapyImmune functionMastectomy

Outcome Measures

Primary Outcomes (3)

  • The change in total lymphocyte count.

    from patient's blood sample analysis for immunological markers in lab.

    Baseline and twelve weeks after the intervention.

  • The change in neutrophil to lymphocyte ratio.

    from patient's blood sample analysis for immunological markers in lab.

    Baseline and twelve weeks after the intervention.

  • The change in platelet to lymphocyte ratio.

    from patient's blood sample analysis for immunological markers in lab.

    Baseline and twelve weeks after the intervention.

Study Arms (3)

Aerobic exercises and diet protocol group

EXPERIMENTAL

The participant will be managed by aerobic exercise by using a treadmill, two times per week. Its intensity was equivalent to 60-85% of each patient's maximum heart rate and lasted 20 minutes in the first week and 30 minutes after the second week in addition to the diet protocol specific diet designed to boost the immune system through edible seeds and nuts which are rich in proteins, fats, fibers, minerals, and vitamins for twelve weeks.

Other: Aerobic exercisesOther: Diet protocol

Diet protocol group

ACTIVE COMPARATOR

The participant will be managed by a specific diet protocol designed to boost the immune system through edible seeds and nuts which are rich in proteins, fats, fibers, minerals, and vitamins for twelve weeks.

Other: Diet protocol

Aerobic exercises group

ACTIVE COMPARATOR

The participant will be managed by aerobic exercise by using a treadmill, two times per week. Its intensity was equivalent to 60-85% of each patient's maximum heart rate and lasted 20 minutes in the first week and 30 minutes after the second week for twelve weeks as a total treatment time.

Other: Aerobic exercises

Interventions

Aerobic exercise by using the treadmill, two times per week. Its intensity was equivalent to 60-85% of each patient's maximum heart rate and lasted 20 minutes in the first week and 30 minutes in weeks 2-12.

Aerobic exercises and diet protocol groupAerobic exercises group

A specific diet for three months is designed to boost the immune system through edible seeds and nuts which are rich in proteins, fats, fibers, minerals, and vitamins.

Aerobic exercises and diet protocol groupDiet protocol group

Eligibility Criteria

Age40 Years - 60 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale patients
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female post-mastectomy patients.
  • Age range is between 40-60 years old.
  • All patients will enter the study after having their informed consent.
  • All patients are undergoing chemotherapy treatment with AC protocol (Adriamycin with endoxan) for four cycles (every 21 days ).
  • All patients have finished the first stage of chemotherapy treatment

You may not qualify if:

  • Cardiac disease patients.
  • Uncontrolled hypertension patients.
  • Patients with thyroid disease.
  • Patients with lymphatic complications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shaimaa Mohamed Ahmed Elsayeh

Cairo, New Cairo, 02, Egypt

RECRUITING

MeSH Terms

Conditions

Immunologic Deficiency SyndromesBreast Neoplasms

Interventions

Exercise

Condition Hierarchy (Ancestors)

Immune System DiseasesNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Shaimaa MA Elsayeh, PhD

    Cairo University

    STUDY DIRECTOR

Central Study Contacts

Shaimaa MA Elsayeh, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Computer randomization.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The model is composed of the aerobic and diet protocol group (Group A), the diet protocol group (Group B), and the aerobic training group (Group C).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of physical therapy

Study Record Dates

First Submitted

October 8, 2022

First Posted

November 4, 2022

Study Start

May 20, 2022

Primary Completion

February 21, 2023

Study Completion

March 28, 2023

Last Updated

November 4, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations